Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
The European Commission is moving forward with its initiative to restrict the use of Chromium (VI) substances under the REACH Regulation. This transition from the current authorisation system to a restriction-based approach is intended to streamline regulatory procedures while maintaining a high level of protection for human health and the environment.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
From April 13, 2024, producers, importers, and marketers in France must disclose electronic information about products containing endocrine disruptors over 0.1%. This regulation aims to enhance transparency and consumer awareness, with compliance required within six months.
Learn how to handle an extended Safety Data Sheet (e-SDS) effectively. This guide covers steps to ensure your uses and conditions match the provided exposure scenarios, actions to take if they don't, and communication strategies for downstream users. Stay compliant with REACH regulations.
The European Commission postponed the ban on DEHP in medical devices due to concerns about its adverse health effects. Learn about the regulation changes and deadlines for authorization to use DEHP in medical devices. Find out more about DEHP and its effects.
Probiotics and prebiotics are essential for gut health. Learn about the differences between them, the official authorization of the term "probiotics" for food supplements, and the conditions that must be met to use this term on labels.
Food supplements are concentrated sources of nutrients or other substances with a nutritional effect. The industry is facing stricter regulations to ensure safety and efficacy. Regulatory obligations vary by country, with compliance being crucial for safety and accuracy.
Formic acid has been approved as an active substance for TP 2, 3, 4, and 5 from November 1, 2024, to October 31, 2034. The authorization of biocidal products containing it requires risk assessments, user category considerations, and residue analysis to ensure safety.
.png)
.png)
